<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutr Res Pract</journal-id><journal-id journal-id-type="iso-abbrev">Nutr Res Pract</journal-id><journal-id journal-id-type="publisher-id">NRP</journal-id><journal-title-group><journal-title>Nutrition Research and Practice</journal-title></journal-title-group><issn pub-type="ppub">1976-1457</issn><issn pub-type="epub">2005-6168</issn><publisher><publisher-name>The Korean Nutrition Society and the Korean Society of Community Nutrition</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28765775</article-id><article-id pub-id-type="pmc">5537538</article-id><article-id pub-id-type="doi">10.4162/nrp.2017.11.4.290</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Monocyte chemoattractant protein-1 polymorphism interaction with spirulina immunomodulatory effects in healthy Korean elderly: A 16 week, double-blind randomized clinical trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Park</surname><given-names>Hee Jung</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Lee</surname><given-names>Hyun Sook</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Foods and Nutrition, Kookmin University, Seoul 02707, Korea.</aff><aff id="A2"><label>2</label>Department of Food Science and Nutrition, Dongseo University, 47 Jurye-ro, Sasang-gu, Busan 47011, Korea.</aff><author-notes><corresp>
Corresponding Author: Hyun-Sook Lee, Tel. 82-51-320-1794, Fax. 82-51-320-1794, <email>hyunlee@gdsu.dongseo.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>09</day><month>6</month><year>2017</year></pub-date><volume>11</volume><issue>4</issue><fpage>290</fpage><lpage>299</lpage><history><date date-type="received"><day>07</day><month>2</month><year>2017</year></date><date date-type="rev-recd"><day>25</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>11</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9;2017 The Korean Nutrition Society and the Korean Society of Community Nutrition</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>BACKGROUND/OBJECTIVES</title><p>Spirulina is a known a functional food related to lipid profiles, immune functions, and antioxidant capacity. Circulating monocyte chemoattractant protein-1 (MCP-1) level is associated with inflammation markers. Single nucleotide polymorphism in the MCP-1 promoter region -2518 have been identified and shown to affect gene transcription. Gene variation may also impact functional food supplementary effects. The current study investigated the interaction of MCP-1 -2518 polymorphism with spirulina supplements on anti-inflammatory capacity in Korean elderly.</p></sec><sec><title>SUBJECTS/METHODS</title><p>After genotyping, healthy elderly subjects (n = 78) were included in a randomized, double blind, and placebo controlled study. Baseline characteristic, body composition, and dietary intake were measured twice (baseline vs. week 16). For 16 weeks, subjects consumed 8 g either spirulina or placebo daily. Plasma MCP-1, interleukin (IL) -2, IL-6, tumor necrosis factor (TNF)-&#x003b1;, complement (C) 3, immunoglobulin (Ig) G, and Ig A concentrations and lymphocyte proliferation rate (LPR) were analyzed as inflammatory markers.</p></sec><sec><title>RESULTS</title><p>In the placebo group with A/A genotype, MCP-1 level was significantly increased, but the spirulina group with A/A genotype was unchanged. IL-2 was significantly increased only in subjects with spirulina supplementation. TNF-&#x003b1; was significantly reduced in subjects with the G carrier. C3 was significantly increased in the placebo group, particularly when A/A increased more than G, but not when spirulina was ingested. LPR was significantly different only in subjects with A/A genotype; there was a significant increase in phytohemagglutinin and lipopolysaccharide induced LPR in the spirulina group.</p></sec><sec><title>CONCLUSION</title><p>In healthy Korean elderly, spirulina supplementation may influence different inflammatory markers by the MCP-1 genotype. These results may be useful for customized dietary guidelines to improve immune function in Koreans.</p></sec></abstract><kwd-group><kwd>Spirulina</kwd><kwd>monocyte chemoattractant protein-1</kwd><kwd>single nucleotide polymorphism</kwd><kwd>immune system</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Korean Research Foundation</institution></institution-wrap></funding-source><award-id>R04-2003-000-10119-0</award-id></award-group></funding-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Chemokines (CCs) play a variety of roles in intercellular signaling, particularly in the recruitment of leukocytes to inflammation sites [<xref rid="B1" ref-type="bibr">1</xref>]. Monocyte chemotactic protein-1 (MCP-1), also referred to as chemokine ligand 2 (CCL2), promotes transmigration and emigration of circulating monocytes into tissues, and exerts various effect on monocytes, including the induction of superoxide anions and expression of various proinflammatory genes [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">4</xref><xref rid="B5" ref-type="bibr">5</xref>]. MCP-1 levels are elevated in the plasma of older persons in the apparent absence of cardiovascular disease [<xref rid="B6" ref-type="bibr">6</xref>]. Single nucleotide polymorphism (SNP) in the MCP-1 promoter region has been shown to affect gene transcription [<xref rid="B7" ref-type="bibr">7</xref>]. The -2518 G/A polymorphism in the MCP-1 is associated with inflammatory related diseases, including rheumatoid arthritis, and diabetic retinopathy [<xref rid="B8" ref-type="bibr">8</xref><xref rid="B9" ref-type="bibr">9</xref>]. It has also been reported that the G/G genotype of -2518 MCP-1 was associated with susceptibility to cardiovascular disease (CVD) and was identified as a genetic risk factor for severe coronary artery disease [<xref rid="B10" ref-type="bibr">10</xref>].</p><p>Dietary factors may influence gene expression [<xref rid="B11" ref-type="bibr">11</xref><xref rid="B12" ref-type="bibr">12</xref><xref rid="B13" ref-type="bibr">13</xref>]. One case control study [<xref rid="B11" ref-type="bibr">11</xref>] reported a nutrigenetic interaction between dietary vitamin E and thioredoxin and catechol-Omethyltransferase gene polymorphisms on waist circumference. Dietary factors may also alter the risk of inflammatory disease. Many studies have reported that dietary factors such as fish oil, broccoli, and probiotics were associated with anti-inflammatory effects [<xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">15</xref><xref rid="B16" ref-type="bibr">16</xref>]. However, clinical trial outcomes are mixed, which may be due to an interaction between genetic background and dietary intake. Gene variation may also influence dietary requirements, e.g. the new field of nutritional genomics, and raises the possibility of individual nutritional management for optimal health and disease prevention on the basis of an individual genome. Multiple studies have already shown significant gene &#x000d7; diet interactions. Ortega-Azor&#x000ed;n et al. [<xref rid="B17" ref-type="bibr">17</xref>] reported that the association of fat mass and obesity associated (FTO) gene polymorphism with type 2 diabetes depends on diet, and that adherence to the Mediterranean diet counteracts the genetic predisposition. Serrano et al. [<xref rid="B18" ref-type="bibr">18</xref>] showed that metabolic response to 25-hydroxyvitamin D and soybean supplementation was dependent on vitamin D receptor GG genotype. Giacconi et al. [<xref rid="B19" ref-type="bibr">19</xref>] showed the effect of zinc transporter protein 2 Gln/Arg/Leu polymorphism on proinflammatory mediators and zinc homeostasis in the elderly population. Park et al. [<xref rid="B20" ref-type="bibr">20</xref>] showed gene-nutrient interactions between transient receptor potential vanilloid-1 variants re161364 and preference for oily taste, intake of oily foods, and fat intake. Thus supplements may have different effects depending on genetic predisposition. However, little is known about the association of MCP-1 polymorphism and dietary factors as nutrients or supplements in the Korean population.</p><p>Spirulina is a cyanobacterial blue-green algae, commonly used as a dietary supplement [<xref rid="B21" ref-type="bibr">21</xref>]. Several studies have demonstrated spirulina's beneficial effects and therapeutic functions [<xref rid="B22" ref-type="bibr">22</xref><xref rid="B23" ref-type="bibr">23</xref>]. Other studies have shown that spirulina has beneficial effects on the treatment of malnutrition and other pathologies such as obesity, hypercholesterolemia, hypertension, and diabetes mellitus [<xref rid="B24" ref-type="bibr">24</xref><xref rid="B25" ref-type="bibr">25</xref><xref rid="B26" ref-type="bibr">26</xref>]. Studies have reported spirulina was associated with modulation of the host immune system. Hayashi et al. [<xref rid="B27" ref-type="bibr">27</xref>] first published detailed studies on the immunomodulatory properties of dietary spirulina in mice. Dietary spirulina enhanced responses of phagocytic activity responses, interleukin (IL) -1b expression, and tumor necrosis factor (TNF)-&#x003b1; genes in carp [<xref rid="B28" ref-type="bibr">28</xref>]. Spirulina treated chicken macrophages showed increased spreading and vacuolization with minimal cytotoxicity [<xref rid="B29" ref-type="bibr">29</xref>]. In humans, spirulina increases natural killer cell cytotoxicity [<xref rid="B30" ref-type="bibr">30</xref>] and ameliorates immunosenescence in older subjects [<xref rid="B31" ref-type="bibr">31</xref>]. Spirulina supplementation produced a significant rise in plasma IL-2 level, and a significant reduction in IL-6 level in health elderly [<xref rid="B32" ref-type="bibr">32</xref>]. These results suggest that spirulina somehow stimulates the immune system.</p><p>From the perspective of personalized nutrition, the effect of spirulina on immune function is different depending on the individual's obesity [<xref rid="B33" ref-type="bibr">33</xref>]. No studies have investigated the effect of MCP-1 polymorphism on the effect of spirulina supplementation on immune function. Therefore, the aim of the current study was to explore interactions between spirulina supplementation and MCP-1 -2518 G/A polymorphism on immunity in Korean elderly.</p></sec><sec sec-type="subjects|methods"><title>SUBJECTS AND METHODS</title><sec><title>Subjects and experimental design</title><p>Subjects were recruited through an advertisement in local newspapers (Dec 2005 to June 2006). The subjects were first interviewed by telephone for screening. Exclusion criteria were: current user of vitamin supplements, current drug-user for inflammatory disease (e.g. Crohn disease, rheumatoid arthritis), dyslipidemia, hypertension, concurrent or recent participant in any other intervention study.</p><p>The study protocol was approved by the Institutional Review Board of Ewha Women's University (ECT 109-02-01), and written informed consent was obtained from all study subjects. A randomized, controlled, double blinded, parallel group design study was performed for 78 healthy older adult subject (43 male, 35 female). Subjects consumed spirulina or placebo, 8 g per day, for 16 consecutive weeks. At the first visit of the study, blood was drawn after a minimum of 12 h fasting, defined as the baseline. Blood samples were taken again at the end of the study period. During the intervention period, subjects were asked to keep their usual diet, and prohibited to take any functional food or supplements. Both spirulina and placebo (100% starch) were provided by Earth Spirulina Biotech (Seoul, Korea). Spirulina and placebo were suppled every 2 weeks and compliance was confirmed by telephone twice a week.</p></sec><sec><title>Food consumption and anthropometric measures</title><p>The elderly subjects were interviewed individually to obtain data on food consumption and general characteristics. Food consumption was assessed using the 24 hour recall method. Food intake data was analyzed using CAN-pro 4.0 software [<xref rid="B34" ref-type="bibr">34</xref>].</p><p>Standing height was measured using an anthropometer (Seca 213, Seca Inc. Birmingham, UK). Body weight and composition [body fat (kg), body fat (%), and lean body mass (kg)] were measured using INBODY 2.0 (Biospace co, Seoul, Korea) with subjects wearing light clothing without shoes or socks.</p></sec><sec><title>Blood collection and analysis</title><p>Blood samples collected before and after supplementation from overnight were taken on the beginning day (pretest) and 16<sup>th</sup> week (posttest) of the study period. Fasting blood samples were obtained and sera were kept at 80&#x02103; until measurement. Total cholesterol and triglyceride level were measured using an autoanalyzer (Ekachem DTSC module, Johnson &#x00026; Johnson, New Brunswick, NJ, USA). HDL cholesterol level was determined by autoanalyzer after treating UC infranatant with phosphotungstic acid Mg. LDL cholesterol was calculated as described by Friedewald [<xref rid="B35" ref-type="bibr">35</xref>].</p><p>Plasma MCP-1, IL-2, IL-6, and TNF-&#x003b1; concentrations were determined by enzyme linked immunosorbent assay (ELISA) (Quantikine, R&#x00026;D Systems Inc., Minneapolis, MN, USA) using an ELISA reader (Spectra Max 340, Molecular Devices, CA, USA). Radial immunodiffusion plates (Norpartigen, Behring Co., Marburg, Germany) were used to measure Ig and C3 level. Assays were performed as recommended by the manufactures.</p><p>The proliferation capacity of lymphocytes was analyzed by the Mosmann method [<xref rid="B36" ref-type="bibr">36</xref>]. Fresh blood samples treated with heparin were diluted in phosphate buffered saline (PBS) 1:1, and then cells were separated in 3 mL Ficoll-paque gradient (lymphocyte isolation solution, Histopaque 1077, Sigma, MO, USA) by centrifuge at 1,000 g for 30 min. The isolated peripheral blood mononuclear cells (PBMCs) were seeded at 2 &#x000d7; 10<sup>5</sup> cell per well in a 96-well plate. PBMCs were treated with concanavalin A (ConA, Sigma, MO, USA, 0.5 &#x000b5;g/10 &#x000b5;l), phytohemagglutinin (PHA, ThermoFisher Scientific co., MA, USA, 0.5 &#x000b5;g/10 &#x000b5;l), and lipopolysaccharide (LPS, Sigma, MO, USA, 0.5 &#x000b5;g/10 &#x000b5;l), and then incubated for 68 h in a CO<sub>2</sub> incubator. Viable cell count was estimated by 3-[4, 5-dimethylthizol-2-yl]-2,5-diphenyl tetrazoliumbromide (MTT, Sigma, MO, USA) assay. Peripheral blood lymphocytes proliferation rate (LPR) was estimated by the stimulation index, SI = absorbance of wells with mitogens / absorbance of wells without mitogen. All tests were run in triplicate.</p></sec><sec><title>DNA extraction and analysis of the MCP-1 -2518 G/A polymorphism</title><p>All subjects were genotyped for MCP-1 polymorphism (-2518 G/A) (dbSNP: rs1024611). DNA was extracted from whole blood (QIAamp DNA Blood Kit, Qiagen, Hilden, Germany), and a 649 bp segment of MCP-1 gene including polymorphism sites was amplified by polymerase chain reaction (forward primer: 5&#x02032;-AGT CCA ACC AAG GTT TGT GC-3&#x02032;, and reverse primer 5&#x02032;-TCA TGC TTC GGG TTT TCT CT-3&#x02032;). The presence of MCP-1 polymorphism was determined by restriction fragment length polymorphism (RFLP) assay using <italic>PvuII</italic> enzyme.</p></sec><sec><title>Statistical analysis</title><p>Statistical analysis was conducted using SAS Statistics version 9.4 (SAS Institute, NC, USA). Data are presented as mean &#x000b1; standard error (SE) for placebo and spirulina groups by genotype. Paired t-test was used to analyze mean differences for all measured parameters between baseline and week 16. Repeated measure ANOVA was conducted to examine treatment effects.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Subjects' baseline characteristics</title><p>Seventy-eight healthy subjects were divided into placebo (p, n = 37) and spirulina groups (s, n = 41). The proportions of A/A, G/A, and G/G genotypes were 17% (n = 14, p/s = 5/9), 56% (n = 44, p/s = 19/25), and 25% (n = 20, p/s = 13/7), respectively. Selected baseline characteristics are summarized in <xref ref-type="table" rid="T1">Table 1</xref>. Average subject age was 66.0 years. There were no significant differences in age, BMI, lipid profile, and dietary intake between 2 groups within the same genotype. Three day dietary records showed no significant intergroup and intragroup differences in mean daily intakes of energy, protein, carbohydrates, total fat, vitamin A, vitamin C, and vitamin E.</p></sec><sec><title>Spirulina effects on plasma cytokine based on genotype</title><p>Plasma MCP-1 level did not differ significantly among the intervention group at baseline (placebo 80.9 pg/dL, spirulina 77.8 pg/dL) and after supplementation (placebo 77.2 pg/dL, spirulina 74.3 pg/dL) (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). When the plasma MCP-1 level of subjects was analyzed by genotype, MCP-1 level was significantly increased in the placebo group (<italic>P</italic> &#x0003c; 0.05) with AA genotype, whereas there was no change in the spirulina group (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). No significant difference in the IL-6 level was observed for the intervention group or genotype groups (<xref ref-type="fig" rid="F1">Figs. 1C, 1D</xref>). Plasma TNF-&#x003b1; level was significantly decreased after spirulina supplementation for all subjects (<xref ref-type="fig" rid="F1">Fig. 1E</xref>, <italic>P</italic> &#x0003c; 0.05), but this significance was not observed for genotype subgroups (<xref ref-type="fig" rid="F1">Fig. 1F</xref>). IL-2 level was significantly increased in the spirulina group after supplementation (<xref ref-type="fig" rid="F1">Fig. 1G</xref>), and the significant was observed in all genotypes (<xref ref-type="fig" rid="F1">Fig. 1H</xref>).</p><p><xref ref-type="table" rid="T2">Table 2</xref> shows the cytokine changes after spirulina intervention between the A/A genotype (n = 14) and G/A + G/G MCP-1 genotypes (n = 64). There were significant differences in plasma MCP-1 levels for MCP-1 genotype and MCP-1 genotype &#x000d7; spirulina treatment (<italic>P</italic> &#x0003c; 0.01, <italic>P</italic> &#x0003c; 0.05), whereas there were no significant differences in IL-6 levels. The level of IL-2 increased in the spirulina group (<italic>P</italic> &#x0003c; 0.05) but not in the placebo group, irrespectively of MCP-1 genotype. Although TNF-&#x003b1; level was significantly decreased (<italic>P</italic> &#x0003c; 0.05) in both groups with G carriers, there was no significant difference by genotype after supplementation.</p></sec><sec><title>Spirulina effects on complement and Ig based on genotype</title><p>C3 level significantly increased after placebo supplementation for 16 weeks (<xref ref-type="fig" rid="F2">Fig. 2A</xref>, <italic>P</italic> &#x0003c; 0.05). However, C3 level was not changed in all groups after spirulina supplementation, but only for subjects with A genotype (<italic>P</italic> &#x0003c; 0.05) (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). There were no significant differences of IgA and IgG levels in all genotypes after spirulina supplementation (<xref ref-type="fig" rid="F2">Figs. 2D and 2F</xref>).</p><p><xref ref-type="table" rid="T3">Table 3</xref> shows C3 and Ig changes after placebo or spirulina supplementation for the A and G genotype subgroups. There was significant spirulina supplementation effect on C3 level (<italic>P</italic> &#x0003c; 0.01), and also MCP-1 genotype &#x000d7; treatment for C3 (<italic>P</italic> &#x0003c; 0.05).</p></sec><sec><title>Spirulina effects on lymphocyte proliferation rate based on genotype</title><p>Lymphocyte proliferation rate showed no significant difference for all subjects after spirulina or placebo supplementation (<xref ref-type="fig" rid="F3">Figs. 3A, 3C, 3E</xref>). Changes in stimulation index of mitogen induced LPR from PBMC are shown in <xref ref-type="fig" rid="F3">Figs. 3B, 3D, and 3F</xref> by genotype. PHA induced SI was significantly changed for A/A and G/A genotypes (<xref ref-type="fig" rid="F3">Fig. 3D</xref>, <italic>P</italic> &#x0003c; 0.05). LPS induced SI was significantly changed only for the A/A genotype (<xref ref-type="fig" rid="F3">Fig. 3F</xref>, <italic>P</italic> &#x0003c; 0.05).</p><p>A significant difference of intervention between the A and G genotype subgroups appeared in PHA and LPS induced proliferation rate with A carrier (<xref ref-type="table" rid="T4">Table 4</xref>). Mitogen induced proliferation of lymphocyte was not significantly changed for both G carrier groups. A significant supplementary effect was observed for the case of PHA induced SI, regardless of genotype (<italic>P</italic> &#x0003c; 0.01).</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>MCP-1 is a small cytokine that belongs to the CC chemokine family [<xref rid="B37" ref-type="bibr">37</xref>]. The concentration gradient of MCP-1 is responsible for the movement of mononuclear cells to inflammation sites [<xref rid="B38" ref-type="bibr">38</xref>]. MCP-1 is produced by a variety of cell types, including immune and non-immune cells [<xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">4</xref><xref rid="B7" ref-type="bibr">7</xref><xref rid="B39" ref-type="bibr">39</xref><xref rid="B40" ref-type="bibr">40</xref>], in response to stimulation by a broad range of mediators, including cytokines, growth factors and mitogens [<xref rid="B4" ref-type="bibr">4</xref>]. MCP-1 recruits monocytes, memory T cells, and dendritic cells to inflammation sites produced by either tissue injury or infection [<xref rid="B38" ref-type="bibr">38</xref><xref rid="B41" ref-type="bibr">41</xref>]. MCP-1 is also implicated in pathogeneses of several diseases characterized by monocytic infiltrates, such as psoriasis, rheumatoid arthritis, and atherosclerosis [<xref rid="B40" ref-type="bibr">40</xref>]. Epidemiological evidence suggests that MCP-1 plasma levels are associated with traditional risk factors for CVD, such as hyperlipidemia, hypertension, and diabetes [<xref rid="B42" ref-type="bibr">42</xref><xref rid="B43" ref-type="bibr">43</xref>]. MCP-1 may also contribute to thrombotic aspects of advanced atherosclerotic lesions, a late complication of atherosclerosis responsible for myocardial infarctions and strokes [<xref rid="B37" ref-type="bibr">37</xref>]. MCP-1 expression is up-regulated in human atherosclerotic plaques [<xref rid="B37" ref-type="bibr">37</xref>], suggesting that genetic factors leading to MCP-1 production deregulation could affect development of atherosclerosis and associated diseases.</p><p>The human MCP-1 gene is located on chromosome 17q11.2-q21.1 [<xref rid="B37" ref-type="bibr">37</xref>]. Several MCP-1 SNPs, such as -1811 A/G, -2136 A/T, -2518 A/G, -2835 C/A, -927 G/, 764 C/G, and 3726 T/C have been identified [<xref rid="B44" ref-type="bibr">44</xref>]. Among these, MCP-1 -2518 A/G SNP, located in the MCP-1 regulatory region, has been most frequently studied for its relevance to diet and disease. Szalai et al. [<xref rid="B44" ref-type="bibr">44</xref>] found that MCP-1 -2518<sup>*</sup>G allele homozygotes frequency was significantly higher in coronary artery disease (CAD) patients than in healthy controls. The higher MCP-1 -2518<sup>*</sup>G homozygotes prevalence was observed in patients with history of stroke [<xref rid="B45" ref-type="bibr">45</xref>] and myocardial infarction [<xref rid="B46" ref-type="bibr">46</xref>]. Angeles-Martinez showed that MCP-1 polymorphisms were associated with premature coronary artery disease risk [<xref rid="B47" ref-type="bibr">47</xref>]. Other studies [<xref rid="B48" ref-type="bibr">48</xref><xref rid="B49" ref-type="bibr">49</xref>] have reported MCP-1 polymorphism association with disease related inflammation susceptibility.</p><p>Several studies have investigated the relationship between MCP-1 -2518A/G polymorphism and CVD risk in various populations worldwide [<xref rid="B50" ref-type="bibr">50</xref><xref rid="B51" ref-type="bibr">51</xref><xref rid="B52" ref-type="bibr">52</xref><xref rid="B53" ref-type="bibr">53</xref>]. However, the results are inconsistent, and MCP-1 -2518 A/G polymorphism appears to be ethnically different. Caucasian or African subjects are less likely to express MCP-1 -2518 G/G polymorphism than Asian or Mexican [<xref rid="B7" ref-type="bibr">7</xref>]. On the other hand, Caucasian or African subjects with MCP-1 -2518 G/G polymorphism show higher MCP-1 plasma levels and higher CVD risk, such as hypertension, than those with other genotypes [<xref rid="B54" ref-type="bibr">54</xref>]. In Chinese subjects, MCP-1 -2518 A/G polymorphism was not associated with CAD risk [<xref rid="B50" ref-type="bibr">50</xref>]. In a previous study, we reported that subjects with A/A genotype exhibited higher MCP-1 levels than other genotypes in Korean elderly, and had higher CVD risk [<xref rid="B55" ref-type="bibr">55</xref>]. These results suggest that MCP-1 concentration and CVD risk vary with MCP-1 polymorphism.</p><p>In the current study, the effects of spirulina supplementation were different depending on MCP-1 genotypes. Anti-inflammatory spirulina supplementation effects in all subjects were not significant, but the effect of intervention was significantly different when analyzed by genotype. For A/A genotype subjects, spirulina supplementation showed significant changes for plasma IL-2 level and PHA or LPS induced LPR. Placebo subjects showed significant MCP-1 increase, but those who took spirulina did not. Circulating MCP-1 levels are associated with CVD risk factors, since MCP-1 is expressed at high levels in atherosclerotic plaque [<xref rid="B52" ref-type="bibr">52</xref><xref rid="B53" ref-type="bibr">53</xref><xref rid="B54" ref-type="bibr">54</xref><xref rid="B57" ref-type="bibr">57</xref>]. IL-2 is a representative anti-inflammatory cytokine that decreases with aging [<xref rid="B58" ref-type="bibr">58</xref>].</p><p>C3 is a protein with a central role in the innate immune system, and C3 levels have an aging dependent increase in general. Several studies have reported that C3 was positively related to CVD [<xref rid="B59" ref-type="bibr">59</xref><xref rid="B60" ref-type="bibr">60</xref>]. In the current study, placebo subjects showed significant C3 level increase after 16 weeks, but there was no significant difference in spirulina subjects. Subjects with A/A genotypes also had significantly more C3 compared with G/A and G/G genotypes when analyzed by genotype and placebo supplementation: A/A increased 32.8%, and G/A and G/G increased 7.5%. These results indicate that the degree of C3 increase depends on the MCP-1 genotype and that C3 increase was suppressed when spirulina was ingested.</p><p>Mitogens, such as PHA, ConA, and LPS induced stimulation index, are generally reduced by aging [<xref rid="B61" ref-type="bibr">61</xref>]. The current study shows that lymphocyte proliferation was improved after spirulina supplementation. Subjects who consumed spirulina for 16 weeks showed significantly increased PHA and LPS induced stimulation index. Significantly, the PHA and LPS induced stimulation index also increased in A/A genotype subjects.</p><p>Thus, spirulina supplementation shows anti-inflammatory effects, such as decreasing MCP-1 level and increasing IL-2 level in healthy subjects, and improved LPS and PHA induced mitogenesis. Theses anti-inflammatory effects were larger for A/A genotype subjects. Therefore, spirulina may be considered beneficial for anti-inflammatory capacity, particularly for A/A genotype subjects.</p><p>In conclusion, functional food supplementation has different effects by genotype. Spirulina supplementation affects anti-inflammatory capacity and may help immune function. Although the population size of the current study was small, the study confirmed that supplement response and anti-inflammatory profiles were different by MCP-1 genotype. These results suggest that personalized management could be advantageous for different genotypes. While the current study is insufficient to make specific personalized nutritional recommendations based on genetic information, the results provide a valuable basis for further study to investigate the relationship between MCP-1 polymorphism and diet. Careful attention should be paid for subsequent studies to include sufficient subjects for each phenotype and genotype with appropriate statistical power.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>Financial aid from the Korean Research Foundation and ES Biotech is gratefully acknowledged. The authors would like to thank the elderly who participated in this study, as well as the staff of Ewha Women's University for their invaluable efforts to make the study possible.</p></ack><fn-group><fn fn-type="supported-by"><p>This work was supported by the Korean Research Foundation Fund grant No. R04-2003-000-10119-0.</p></fn><fn fn-type="COI-statement"><p><bold>CONFLICT OF INTEREST:</bold> The authors declare no potential conflicts of interests.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>WA</given-names></name></person-group><article-title>Getting leukocytes to the site of inflammation</article-title><source>Vet Pathol</source><year>2013</year><volume>50</volume><fpage>7</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">23345459</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Rocnik</surname><given-names>E</given-names></name><name><surname>Rahlpour</surname><given-names>R</given-names></name><name><surname>Hunter</surname><given-names>N</given-names></name><name><surname>Pickering</surname><given-names>G</given-names></name><name><surname>Kelvin</surname><given-names>DJ</given-names></name></person-group><article-title>MCP-1 induces proliferation and migration of vascular smooth muscle cells</article-title><source>FASEB J</source><year>1996</year><volume>10</volume><fpage>A1932</fpage></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luster</surname><given-names>AD</given-names></name></person-group><article-title>Chemokines--chemotactic cytokines that mediate inflammation</article-title><source>N Engl J Med</source><year>1998</year><volume>338</volume><fpage>436</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">9459648</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>D</given-names></name><name><surname>Zlotnik</surname><given-names>A</given-names></name></person-group><article-title>The biology of chemokines and their receptors</article-title><source>Annu Rev Immunol</source><year>2000</year><volume>18</volume><fpage>217</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">10837058</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salcedo</surname><given-names>R</given-names></name><name><surname>Ponce</surname><given-names>ML</given-names></name><name><surname>Young</surname><given-names>HA</given-names></name><name><surname>Wasserman</surname><given-names>K</given-names></name><name><surname>Ward</surname><given-names>JM</given-names></name><name><surname>Kleinman</surname><given-names>HK</given-names></name><name><surname>Oppenheim</surname><given-names>JJ</given-names></name><name><surname>Murphy</surname><given-names>WJ</given-names></name></person-group><article-title>Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression</article-title><source>Blood</source><year>2000</year><volume>96</volume><fpage>34</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">10891427</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inadera</surname><given-names>H</given-names></name><name><surname>Egashira</surname><given-names>K</given-names></name><name><surname>Takemoto</surname><given-names>M</given-names></name><name><surname>Ouchi</surname><given-names>Y</given-names></name><name><surname>Matsushima</surname><given-names>K</given-names></name></person-group><article-title>Increase in circulating levels of monocyte chemoattractant protein-1 with aging</article-title><source>J Interferon Cytokine Res</source><year>1999</year><volume>19</volume><fpage>1179</fpage><lpage>1182</lpage><pub-id pub-id-type="pmid">10547158</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rovin</surname><given-names>BH</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name></person-group><article-title>A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression</article-title><source>Biochem Biophys Res Commun</source><year>1999</year><volume>259</volume><fpage>344</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">10362511</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>ES</given-names></name><name><surname>Schneeberger</surname><given-names>EE</given-names></name><name><surname>Aranda</surname><given-names>FM</given-names></name><name><surname>Peres</surname><given-names>SW</given-names></name><name><surname>Del Carmen Valerio</surname><given-names>M</given-names></name><name><surname>de Los Angeles Correa</surname><given-names>M</given-names></name><name><surname>Pra</surname><given-names>FD</given-names></name><name><surname>Martinez</surname><given-names>L</given-names></name><name><surname>Remondino</surname><given-names>G</given-names></name><name><surname>de Larra&#x000f1;aga</surname><given-names>G</given-names></name><name><surname>Citera</surname><given-names>G</given-names></name></person-group><article-title>The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene (MCP-1) is associated with an increased risk of rheumatoid arthritis in Argentine patients</article-title><source>Clin Rheumatol</source><year>2016</year><volume>35</volume><fpage>3057</fpage><lpage>3061</lpage><pub-id pub-id-type="pmid">27530408</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name></person-group><article-title>Association of monocyte chemoattractant protein-1 gene 2518A/G polymorphism with diabetic retinopathy in type 2 diabetes mellitus: a meta-analysis</article-title><source>Diabetes Res Clin Pract</source><year>2016</year><volume>120</volume><fpage>40</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">27505625</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>J</given-names></name><name><surname>Kolattukudy</surname><given-names>PE</given-names></name></person-group><article-title>Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications</article-title><source>Clin Sci (Lond)</source><year>2009</year><volume>117</volume><fpage>95</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">19566488</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansego</surname><given-names>ML</given-names></name><name><surname>De Marco</surname><given-names>G</given-names></name><name><surname>Ivorra</surname><given-names>C</given-names></name><name><surname>Lopez-Izquierdo</surname><given-names>R</given-names></name><name><surname>Morcillo</surname><given-names>S</given-names></name><name><surname>Rojo-Mart&#x000ed;nez</surname><given-names>G</given-names></name><name><surname>Gonz&#x000e1;lez-Albert</surname><given-names>V</given-names></name><name><surname>Martinez</surname><given-names>F</given-names></name><name><surname>Soriguer</surname><given-names>F</given-names></name><name><surname>Mart&#x000ed;n-Escudero</surname><given-names>JC</given-names></name><name><surname>Redon</surname><given-names>J</given-names></name><name><surname>Chaves</surname><given-names>FJ</given-names></name></person-group><article-title>The nutrigenetic influence of the interaction between dietary vitamin E and TXN and COMT gene polymorphisms on waist circumference: a case control study</article-title><source>J Transl Med</source><year>2015</year><volume>13</volume><fpage>286</fpage><pub-id pub-id-type="pmid">26329592</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pase</surname><given-names>CS</given-names></name><name><surname>Teixeira</surname><given-names>AM</given-names></name><name><surname>Roversi</surname><given-names>K</given-names></name><name><surname>Dias</surname><given-names>VT</given-names></name><name><surname>Calabrese</surname><given-names>F</given-names></name><name><surname>Molteni</surname><given-names>R</given-names></name><name><surname>Franchi</surname><given-names>S</given-names></name><name><surname>Panerai</surname><given-names>AE</given-names></name><name><surname>Riva</surname><given-names>MA</given-names></name><name><surname>Burger</surname><given-names>ME</given-names></name></person-group><article-title>Olive oil-enriched diet reduces brain oxidative damages and ameliorates neurotrophic factor gene expression in different life stages of rats</article-title><source>J Nutr Biochem</source><year>2015</year><volume>26</volume><fpage>1200</fpage><lpage>1207</lpage><pub-id pub-id-type="pmid">26168701</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietropaolo</surname><given-names>S</given-names></name><name><surname>Goubran</surname><given-names>MG</given-names></name><name><surname>Joffre</surname><given-names>C</given-names></name><name><surname>Aubert</surname><given-names>A</given-names></name><name><surname>Lemaire-Mayo</surname><given-names>V</given-names></name><name><surname>Crusio</surname><given-names>WE</given-names></name><name><surname>Lay&#x000e9;</surname><given-names>S</given-names></name></person-group><article-title>Dietary supplementation of omega-3 fatty acids rescues fragile X phenotypes in Fmr1-Ko mice</article-title><source>Psychoneuroendocrinology</source><year>2014</year><volume>49</volume><fpage>119</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">25080404</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nigam</surname><given-names>A</given-names></name><name><surname>Talajic</surname><given-names>M</given-names></name><name><surname>Roy</surname><given-names>D</given-names></name><name><surname>Nattel</surname><given-names>S</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name><name><surname>Nozza</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>P</given-names></name><name><surname>Ramprasath</surname><given-names>VR</given-names></name><name><surname>O'Hara</surname><given-names>G</given-names></name><name><surname>Kopecky</surname><given-names>S</given-names></name><name><surname>Brophy</surname><given-names>JM</given-names></name><name><surname>Tardif</surname><given-names>JC</given-names></name></person-group><collab>AFFORD Investigators</collab><article-title>Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress</article-title><source>J Am Coll Cardiol</source><year>2014</year><volume>64</volume><fpage>1441</fpage><lpage>1448</lpage><pub-id pub-id-type="pmid">25277614</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanaka</surname><given-names>A</given-names></name><name><surname>Fahey</surname><given-names>JW</given-names></name><name><surname>Fukumoto</surname><given-names>A</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Inoue</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Tauchi</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Hyodo</surname><given-names>I</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans</article-title><source>Cancer Prev Res (Phila)</source><year>2009</year><volume>2</volume><fpage>353</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">19349290</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicari</surname><given-names>E</given-names></name><name><surname>La Vignera</surname><given-names>S</given-names></name><name><surname>Castiglione</surname><given-names>R</given-names></name><name><surname>Condorelli</surname><given-names>RA</given-names></name><name><surname>Vicari</surname><given-names>LO</given-names></name><name><surname>Calogero</surname><given-names>AE</given-names></name></person-group><article-title>Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3</article-title><source>Asian J Androl</source><year>2014</year><volume>16</volume><fpage>735</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">24969056</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega-Azor&#x000ed;n</surname><given-names>C</given-names></name><name><surname>Sorl&#x000ed;</surname><given-names>JV</given-names></name><name><surname>Asensio</surname><given-names>EM</given-names></name><name><surname>Coltell</surname><given-names>O</given-names></name><name><surname>Mart&#x000ed;nez-Gonz&#x000e1;lez</surname><given-names>MA</given-names></name><name><surname>Salas-Salvad&#x000f3;</surname><given-names>J</given-names></name><name><surname>Covas</surname><given-names>MI</given-names></name><name><surname>Ar&#x000f3;s</surname><given-names>F</given-names></name><name><surname>Lapetra</surname><given-names>J</given-names></name><name><surname>Serra-Majem</surname><given-names>L</given-names></name><name><surname>G&#x000f3;mez-Gracia</surname><given-names>E</given-names></name><name><surname>Fiol</surname><given-names>M</given-names></name><name><surname>S&#x000e1;ez-Tormo</surname><given-names>G</given-names></name><name><surname>Pint&#x000f3;</surname><given-names>X</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>MA</given-names></name><name><surname>Ros</surname><given-names>E</given-names></name><name><surname>Ordov&#x000e1;s</surname><given-names>JM</given-names></name><name><surname>Estruch</surname><given-names>R</given-names></name><name><surname>Corella</surname><given-names>D</given-names></name></person-group><article-title>Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low</article-title><source>Cardiovasc Diabetol</source><year>2012</year><volume>11</volume><fpage>137</fpage><pub-id pub-id-type="pmid">23130628</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serrano</surname><given-names>JC</given-names></name><name><surname>De Lorenzo</surname><given-names>D</given-names></name><name><surname>Cassanye</surname><given-names>A</given-names></name><name><surname>Mart&#x000ed;n-Gari</surname><given-names>M</given-names></name><name><surname>Espinel</surname><given-names>A</given-names></name><name><surname>Delgado</surname><given-names>MA</given-names></name><name><surname>Pamplona</surname><given-names>R</given-names></name><name><surname>Portero-Otin</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D receptor BsmI polymorphism modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease risk factors profile</article-title><source>Genes Nutr</source><year>2013</year><volume>8</volume><fpage>561</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">24158768</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacconi</surname><given-names>R</given-names></name><name><surname>Costarelli</surname><given-names>L</given-names></name><name><surname>Malavolta</surname><given-names>M</given-names></name><name><surname>Cardelli</surname><given-names>M</given-names></name><name><surname>Galeazzi</surname><given-names>R</given-names></name><name><surname>Piacenza</surname><given-names>F</given-names></name><name><surname>Gasparini</surname><given-names>N</given-names></name><name><surname>Basso</surname><given-names>A</given-names></name><name><surname>Mariani</surname><given-names>E</given-names></name><name><surname>Fulop</surname><given-names>T</given-names></name><name><surname>Rink</surname><given-names>L</given-names></name><name><surname>Dedoussis</surname><given-names>G</given-names></name><name><surname>Herbein</surname><given-names>G</given-names></name><name><surname>Jajte</surname><given-names>J</given-names></name><name><surname>Provinciali</surname><given-names>M</given-names></name><name><surname>Busco</surname><given-names>F</given-names></name><name><surname>Mocchegiani</surname><given-names>E</given-names></name></person-group><article-title>Effect of ZIP2 Gln/Arg/Leu (rs2234632) polymorphism on zinc homeostasis and inflammatory response following zinc supplementation</article-title><source>Biofactors</source><year>2015</year><volume>41</volume><fpage>414</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">26643924</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>NR</given-names></name><name><surname>Jin</surname><given-names>HS</given-names></name></person-group><article-title>TRPV1 gene polymorphisms are associated with type 2 diabetes by their interaction with fat consumption in the Korean genome epidemiology study</article-title><source>J Nutrigenet Nutrigenomics</source><year>2016</year><volume>9</volume><fpage>47</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">27287034</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thengodkar</surname><given-names>RR</given-names></name><name><surname>Sivakami</surname><given-names>S</given-names></name></person-group><article-title>Degradation of Chlorpyrifos by an alkaline phosphatase from the cyanobacterium Spirulina platensis</article-title><source>Biodegradation</source><year>2010</year><volume>21</volume><fpage>637</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">20127145</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JB</given-names></name><name><surname>Srisomporn</surname><given-names>P</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Sankawa</surname><given-names>U</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name></person-group><article-title>Effects of structural modification of calcium spirulan, a sulfated polysaccharide from Spirulina platensis, on antiviral activity</article-title><source>Chem Pharm Bull (Tokyo)</source><year>2001</year><volume>49</volume><fpage>108</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">11201213</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcel</surname><given-names>AK</given-names></name><name><surname>Ekali</surname><given-names>LG</given-names></name><name><surname>Eugene</surname><given-names>S</given-names></name><name><surname>Arnold</surname><given-names>OE</given-names></name><name><surname>Sandrine</surname><given-names>ED</given-names></name><name><surname>von der Weid</surname><given-names>D</given-names></name><name><surname>Gbaguidi</surname><given-names>E</given-names></name><name><surname>Ngogang</surname><given-names>J</given-names></name><name><surname>Mbanya</surname><given-names>JC</given-names></name></person-group><article-title>The effect of Spirulina platensis versus soybean on insulin resistance in HIV-infected patients: a randomized pilot study</article-title><source>Nutrients</source><year>2011</year><volume>3</volume><fpage>712</fpage><lpage>724</lpage><pub-id pub-id-type="pmid">22254118</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nkengfack</surname><given-names>G</given-names></name><name><surname>Torimiro</surname><given-names>J</given-names></name><name><surname>Ngogang</surname><given-names>J</given-names></name><name><surname>Heike</surname><given-names>E</given-names></name></person-group><article-title>Effects of nutritional education and lifestyle modification on the nutritional status of HIV positive patients: results of a cluster randomized intervention over a period of six months</article-title><source>Glob Epidemi Obes</source><year>2013</year><volume>1</volume><fpage>5</fpage></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moura</surname><given-names>LP</given-names></name><name><surname>Puga</surname><given-names>GM</given-names></name><name><surname>Beck</surname><given-names>WR</given-names></name><name><surname>Teixeira</surname><given-names>IP</given-names></name><name><surname>Ghezzi</surname><given-names>AC</given-names></name><name><surname>Silva</surname><given-names>GA</given-names></name><name><surname>Mello</surname><given-names>MA</given-names></name></person-group><article-title>Exercise and Spirulina control non-alcoholic hepatic steatosis and lipid profile in diabetic Wistar rats</article-title><source>Lipids Health Dis</source><year>2011</year><volume>10</volume><fpage>77</fpage><pub-id pub-id-type="pmid">21569626</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Layam</surname><given-names>A</given-names></name><name><surname>Reddy</surname><given-names>CL</given-names></name></person-group><article-title>Antidiabetic property of Spirulina</article-title><source>Diabetol Croat</source><year>2007</year><volume>35</volume><fpage>29</fpage><lpage>33</lpage></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>O</given-names></name><name><surname>Katoh</surname><given-names>T</given-names></name><name><surname>Okuwaki</surname><given-names>Y</given-names></name></person-group><article-title>Enhancement of antibody production in mice by dietary Spirulina platensis</article-title><source>J Nutr Sci Vitaminol (Tokyo)</source><year>1994</year><volume>40</volume><fpage>431</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">7891204</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanuki</surname><given-names>H</given-names></name><name><surname>Ota</surname><given-names>K</given-names></name><name><surname>Tassakka</surname><given-names>AC</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Sakai</surname><given-names>M</given-names></name></person-group><article-title>Immunostimulant effects of dietary Spirulina platensis on carp, Cyprinus carpio</article-title><source>Aquaculture</source><year>2006</year><volume>258</volume><fpage>157</fpage><lpage>163</lpage></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>MA</given-names></name><name><surname>Kidd</surname><given-names>MT</given-names></name><name><surname>Ali</surname><given-names>RA</given-names></name></person-group><article-title>Spirulina platensis extract enhances chicken macrophages functions after in vitro exposure</article-title><source>J Nutr Immunol</source><year>1996</year><volume>3</volume><fpage>35</fpage><lpage>45</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirahashi</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Hazeki</surname><given-names>K</given-names></name><name><surname>Saeki</surname><given-names>Y</given-names></name><name><surname>Ui</surname><given-names>M</given-names></name><name><surname>Seya</surname><given-names>T</given-names></name></person-group><article-title>Activation of the human innate immune system by Spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina platensis</article-title><source>Int Immunopharmacol</source><year>2002</year><volume>2</volume><fpage>423</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">11962722</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selmi</surname><given-names>C</given-names></name><name><surname>Leung</surname><given-names>PS</given-names></name><name><surname>Fischer</surname><given-names>L</given-names></name><name><surname>German</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>CY</given-names></name><name><surname>Kenny</surname><given-names>TP</given-names></name><name><surname>Cysewski</surname><given-names>GR</given-names></name><name><surname>Gershwin</surname><given-names>ME</given-names></name></person-group><article-title>The effects of Spirulina on anemia and immune function in senior citizens</article-title><source>Cell Mol Immunol</source><year>2011</year><volume>8</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">21278762</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Ryu</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>MH</given-names></name><name><surname>Chung</surname><given-names>HW</given-names></name><name><surname>Kim</surname><given-names>WY</given-names></name></person-group><article-title>A randomized double-blind, placebo-controlled study to establish the effects of Spirulina in elderly Koreans</article-title><source>Ann Nutr Metab</source><year>2008</year><volume>52</volume><fpage>322</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">18714150</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name></person-group><article-title>The influence of obesity on the effects of Spirulina supplementation in the human metabolic response of Korean elderly</article-title><source>Nutr Res Pract</source><year>2016</year><volume>10</volume><fpage>418</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">27478549</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="book"><collab>The Korean Nutrition Society</collab><source>CAN-Pro 4.0: nutritional assessment program</source><publisher-loc>Seoul</publisher-loc><publisher-name>The Korean Nutrition Society</publisher-name><year>2010</year></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>WT</given-names></name><name><surname>Levy</surname><given-names>RI</given-names></name><name><surname>Fredrickson</surname><given-names>DS</given-names></name></person-group><article-title>Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title><source>Clin Chem</source><year>1972</year><volume>18</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">4337382</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosmann</surname><given-names>T</given-names></name></person-group><article-title>Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</article-title><source>J Immunol Methods</source><year>1983</year><volume>65</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">6606682</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bielinski</surname><given-names>SJ</given-names></name><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Miller</surname><given-names>MB</given-names></name><name><surname>Hopkins</surname><given-names>PN</given-names></name><name><surname>Eckfeldt</surname><given-names>JH</given-names></name><name><surname>Hixson</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Register</surname><given-names>T</given-names></name><name><surname>Myers</surname><given-names>RH</given-names></name><name><surname>Arnett</surname><given-names>DK</given-names></name></person-group><article-title>Circulating MCP-1 levels shows linkage to chemokine receptor gene cluster on chromosome 3: the NHLBI family heart study follow-up examination</article-title><source>Genes Immun</source><year>2007</year><volume>8</volume><fpage>684</fpage><lpage>690</lpage><pub-id pub-id-type="pmid">17917677</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshmane</surname><given-names>SL</given-names></name><name><surname>Kremlev</surname><given-names>S</given-names></name><name><surname>Amini</surname><given-names>S</given-names></name><name><surname>Sawaya</surname><given-names>BE</given-names></name></person-group><article-title>Monocyte chemoattractant protein-1 (MCP-1): an overview</article-title><source>J Interferon Cytokine Res</source><year>2009</year><volume>29</volume><fpage>313</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">19441883</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Eckes</surname><given-names>B</given-names></name><name><surname>Mauch</surname><given-names>C</given-names></name><name><surname>Hartmann</surname><given-names>K</given-names></name><name><surname>Krieg</surname><given-names>T</given-names></name></person-group><article-title>Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>6174</fpage><lpage>6179</lpage><pub-id pub-id-type="pmid">10843667</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>M</given-names></name><name><surname>Sui</surname><given-names>Z</given-names></name></person-group><article-title>Recent developments in CCR2 antagonists</article-title><source>Expert Opin Ther Pat</source><year>2009</year><volume>19</volume><fpage>295</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">19441905</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollins</surname><given-names>BJ</given-names></name></person-group><article-title>Chemokines</article-title><source>Blood</source><year>1997</year><volume>90</volume><fpage>909</fpage><lpage>928</lpage><pub-id pub-id-type="pmid">9242519</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lemos</surname><given-names>JA</given-names></name><name><surname>Morrow</surname><given-names>DA</given-names></name><name><surname>Sabatine</surname><given-names>MS</given-names></name><name><surname>Murphy</surname><given-names>SA</given-names></name><name><surname>Gibson</surname><given-names>CM</given-names></name><name><surname>Antman</surname><given-names>EM</given-names></name><name><surname>McCabe</surname><given-names>CH</given-names></name><name><surname>Cannon</surname><given-names>CP</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name></person-group><article-title>Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes</article-title><source>Circulation</source><year>2003</year><volume>107</volume><fpage>690</fpage><lpage>695</lpage><pub-id pub-id-type="pmid">12578870</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deo</surname><given-names>R</given-names></name><name><surname>Khera</surname><given-names>A</given-names></name><name><surname>McGuire</surname><given-names>DK</given-names></name><name><surname>Murphy</surname><given-names>SA</given-names></name><name><surname>Meo</surname><given-names>Neto</given-names></name><name><surname>Morrow</surname><given-names>DA</given-names></name><name><surname>de Lemos</surname><given-names>JA</given-names></name></person-group><article-title>Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>44</volume><fpage>1812</fpage><lpage>1818</lpage><pub-id pub-id-type="pmid">15519012</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navratilova</surname><given-names>Z</given-names></name></person-group><article-title>Polymorphisms in CCL2&#x00026;CCL5 chemokines/chemokine receptors genes and their association with diseases</article-title><source>Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub</source><year>2006</year><volume>150</volume><fpage>191</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">17426779</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szalai</surname><given-names>C</given-names></name><name><surname>Kozma</surname><given-names>GT</given-names></name><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Bojszk&#x000f3;</surname><given-names>A</given-names></name><name><surname>Krikovszky</surname><given-names>D</given-names></name><name><surname>Szab&#x000f3;</surname><given-names>T</given-names></name><name><surname>Falus</surname><given-names>A</given-names></name></person-group><article-title>Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity</article-title><source>J Allergy Clin Immunol</source><year>2001</year><volume>108</volume><fpage>375</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">11544456</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arakelyan</surname><given-names>A</given-names></name><name><surname>Zakharyan</surname><given-names>R</given-names></name><name><surname>Hambardzumyan</surname><given-names>M</given-names></name><name><surname>Petrkova</surname><given-names>J</given-names></name><name><surname>Olsson</surname><given-names>MC</given-names></name><name><surname>Petrek</surname><given-names>M</given-names></name><name><surname>Boyajyan</surname><given-names>A</given-names></name></person-group><article-title>Functional genetic polymorphisms of monocyte chemoattractant protein 1 and C-C chemokine receptor type 2 in ischemic stroke</article-title><source>J Interferon Cytokine Res</source><year>2014</year><volume>34</volume><fpage>100</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">24083412</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjarnadottir</surname><given-names>K</given-names></name><name><surname>Eiriksdottir</surname><given-names>G</given-names></name><name><surname>Aspelund</surname><given-names>T</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name></person-group><article-title>Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population</article-title><source>Atherosclerosis</source><year>2006</year><volume>188</volume><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">16356504</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeles-Mart&#x000ed;nez</surname><given-names>J</given-names></name><name><surname>Posadas-S&#x000e1;nchez</surname><given-names>R</given-names></name><name><surname>&#x000c1;lvarez-Le&#x000f3;n</surname><given-names>E</given-names></name><name><surname>Villarreal-Molina</surname><given-names>T</given-names></name><name><surname>Cardoso-Salda&#x000f1;a</surname><given-names>G</given-names></name><name><surname>Fragoso</surname><given-names>JM</given-names></name><name><surname>Ju&#x000e1;rez-Rojas</surname><given-names>JG</given-names></name><name><surname>Medina-Urrutia</surname><given-names>A</given-names></name><name><surname>Posadas-Romero</surname><given-names>C</given-names></name><name><surname>Vargas-Alarc&#x000f3;n</surname><given-names>G</given-names></name></person-group><article-title>Monocyte chemoattractant protein-1 gene (MCP-1) polymorphisms are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study</article-title><source>Immunol Lett</source><year>2015</year><volume>167</volume><fpage>125</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">26277553</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Liao</surname><given-names>YF</given-names></name><name><surname>Zhou</surname><given-names>WP</given-names></name><name><surname>Ming</surname><given-names>HL</given-names></name><name><surname>Wang</surname><given-names>QH</given-names></name></person-group><article-title>The MCP-1 gene A-2518G polymorphism confers an increased risk of vascular complications in type 2 diabetes mellitus patients</article-title><source>Genet Test Mol Biomarkers</source><year>2015</year><volume>19</volume><fpage>411</fpage><lpage>417</lpage><pub-id pub-id-type="pmid">26083329</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Mao</surname><given-names>L</given-names></name><name><surname>Shu</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Kijlstra</surname><given-names>A</given-names></name></person-group><article-title>Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism in Chinese Han patients with ocular Beh&#x000e7;et's disease</article-title><source>Hum Immunol</source><year>2010</year><volume>71</volume><fpage>79</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">19782713</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name></person-group><article-title>Association of monocyte chemoattractant protein-1-2518A/G polymorphism and risk of coronary artery disease among the Chinese population: a meta-analysis</article-title><source>Int J Clin Exp Med</source><year>2015</year><volume>8</volume><fpage>15182</fpage><lpage>15189</lpage><pub-id pub-id-type="pmid">26629002</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jemaa</surname><given-names>R</given-names></name><name><surname>Rojbani</surname><given-names>H</given-names></name><name><surname>Kallel</surname><given-names>A</given-names></name><name><surname>Ben Ali</surname><given-names>S</given-names></name><name><surname>Feki</surname><given-names>M</given-names></name><name><surname>Chabrak</surname><given-names>S</given-names></name><name><surname>Elasmi</surname><given-names>M</given-names></name><name><surname>Taieb</surname><given-names>SH</given-names></name><name><surname>Sanhaji</surname><given-names>H</given-names></name><name><surname>Souheil</surname><given-names>O</given-names></name><name><surname>Mechmeche</surname><given-names>R</given-names></name><name><surname>Kaabachi</surname><given-names>N</given-names></name></person-group><article-title>Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients</article-title><source>Clin Chim Acta</source><year>2008</year><volume>390</volume><fpage>122</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">18230355</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>R</given-names></name><name><surname>Matharoo</surname><given-names>K</given-names></name><name><surname>Arora</surname><given-names>P</given-names></name><name><surname>Bhanwer</surname><given-names>AJ</given-names></name></person-group><article-title>Association of -2518A&#x0003e;G promoter polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene with type 2 diabetes and coronary artery disease</article-title><source>Genet Test Mol Biomarkers</source><year>2013</year><volume>17</volume><fpage>750</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">23930970</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okopie&#x00144;</surname><given-names>B</given-names></name><name><surname>Haberka</surname><given-names>M</given-names></name><name><surname>Cwalina</surname><given-names>L</given-names></name><name><surname>Kowalski</surname><given-names>J</given-names></name><name><surname>Belowski</surname><given-names>D</given-names></name><name><surname>Madej</surname><given-names>A</given-names></name><name><surname>Zieli&#x00144;ski</surname><given-names>M</given-names></name><name><surname>Krysiak</surname><given-names>R</given-names></name><name><surname>Labuzek</surname><given-names>K</given-names></name><name><surname>Kalina</surname><given-names>Z</given-names></name><name><surname>Herman</surname><given-names>ZS</given-names></name></person-group><article-title>Plasma cytokines as predictors of coronary heart disease</article-title><source>Res Commun Mol Pathol Pharmacol</source><year>2002</year><volume>112</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">15080492</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>HH</given-names></name><name><surname>Gao</surname><given-names>LB</given-names></name><name><surname>Wen</surname><given-names>JM</given-names></name></person-group><article-title>Correlations of MCP-1 -2518A&#x0003e;G polymorphism and serum levels with cerebral infarction risk: a meta-analysis</article-title><source>DNA Cell Biol</source><year>2014</year><volume>33</volume><fpage>522</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">24720638</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HJ</given-names></name></person-group><article-title>Association of MCP-1 polymorphism with cardiovascular disease risk factors in Korean elderly</article-title><source>J Nutr Health</source><year>2013</year><volume>46</volume><fpage>511</fpage><lpage>520</lpage></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelken</surname><given-names>NA</given-names></name><name><surname>Coughlin</surname><given-names>SR</given-names></name><name><surname>Gordon</surname><given-names>D</given-names></name><name><surname>Wilcox</surname><given-names>JN</given-names></name></person-group><article-title>Monocyte chemoattractant protein-1 in human atheromatous plaques</article-title><source>J Clin Invest</source><year>1991</year><volume>88</volume><fpage>1121</fpage><lpage>1127</lpage><pub-id pub-id-type="pmid">1843454</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolich-&#x0017d;ugich</surname><given-names>J</given-names></name></person-group><article-title>T cell aging: naive but not young</article-title><source>J Exp Med</source><year>2005</year><volume>201</volume><fpage>837</fpage><lpage>840</lpage><pub-id pub-id-type="pmid">15781575</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halkes</surname><given-names>CJ</given-names></name><name><surname>van Dijk</surname><given-names>H</given-names></name><name><surname>de Jaegere</surname><given-names>PP</given-names></name><name><surname>Plokker</surname><given-names>HW</given-names></name><name><surname>van Der Helm</surname><given-names>Y</given-names></name><name><surname>Erkelens</surname><given-names>DW</given-names></name><name><surname>Castro Cabezas</surname><given-names>M</given-names></name></person-group><article-title>Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2001</year><volume>21</volume><fpage>1526</fpage><lpage>1530</lpage><pub-id pub-id-type="pmid">11557683</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muscari</surname><given-names>A</given-names></name><name><surname>Bozzoli</surname><given-names>C</given-names></name><name><surname>Puddu</surname><given-names>GM</given-names></name><name><surname>Sangiorgi</surname><given-names>Z</given-names></name><name><surname>Dormi</surname><given-names>A</given-names></name><name><surname>Rovinetti</surname><given-names>C</given-names></name><name><surname>Descovich</surname><given-names>GC</given-names></name><name><surname>Puddu</surname><given-names>P</given-names></name></person-group><article-title>Association of serum C3 levels with the risk of myocardial infarction</article-title><source>Am J Med</source><year>1995</year><volume>98</volume><fpage>357</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">7709948</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoskinson</surname><given-names>CD</given-names></name><name><surname>Chew</surname><given-names>BP</given-names></name><name><surname>Wong</surname><given-names>TS</given-names></name></person-group><article-title>Age-related changes in mitogen-induced lymphocyte proliferation and polymorphonuclear neutrophil function in the piglet</article-title><source>J Anim Sci</source><year>1990</year><volume>68</volume><fpage>2471</fpage><lpage>2478</lpage><pub-id pub-id-type="pmid">2401664</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>Plasma cytokine levels for (A) MCP-1, (C) IL-6, (E) TNF-&#x003b1;, and (G) IL-2; and changes (B, D, F, H, respectively) after placebo or spirulina supplementation in subject grouped by MCP-1 polymorphism.</title><p>MCP-1, monocyte chemoattractant protein -1; IL, interleukin; TNF, tumor necrosis factor; A/A, MCP-1 -2518 AA genotype; G/A, MCP-1 -2518 GA genotype; G/G, MCP-1 -2518 GG genotype. Data are expressed as mean &#x000b1; SE. <sup>*</sup><italic>P</italic> &#x0003c; 0.05, <sup>**</sup><italic>P</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="nrp-11-290-g001"/></fig><fig id="F2" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>Plasma level of (A) C3, (C) IgA, and (E) IgG; and changes (B, D, and F, respectively) after placebo or spirulina supplementation in subjects grouped by MCP-1 polymorphism.</title><p>Blood samples were collected before and after supplementation (pretest: beginning day, post-test: 16 weeks). C3, Ig A, and IgG plasma levels were analyzed by radical immunodiffusion plate. MCP-1, monocyte chemoattractant protein 1; C3, complement 3; Ig A, immunoglobulin A; Ig G, immunoglobulin G; A/A, MCP-1 -2518 AA genotype; G/A, MCP-1 -2518 GA genotype; G/G, MCP-1 -2518 GG genotype. Data are expressed as mean &#x000b1; SE. <sup>*</sup><italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="nrp-11-290-g002"/></fig><fig id="F3" orientation="portrait" position="float"><label>Fig. 3</label><caption><title>Lymphocyte proliferation rate: (A) Con A, (B) PHS, and (C) LPS induced; and changes (B, D, and F, respectively) after placebo or spirulina supplementation in subjects grouped by MCP-1 polymorphism.</title><p>Isolated lymphocytes were seeded at 2 &#x000d7; 10<sub>5</sub> cells per well in a 96-well plate and treated with ConA, PHA, or LPS. After incubating for 68 hours in CO<sub>2</sub> incubator, mitogen induced LPR was determined by ELISA. MCP-1, monocyte chemoattractant protein 1; ConA, concanavalin A; PHA, phtyhemagglutinin; LPS, lipopolysaccharide; A/A, MCP-1 -2518 AA genotype; G/A, MCP-1 -2518 GA genotype; G/G, MCP-1 -2518 GG genotype. Data are expressed as mean &#x000b1; SE. <sup>*</sup><italic>P</italic> &#x0003c; 0.05</p></caption><graphic xlink:href="nrp-11-290-g003"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Selected characteristics of study subjects</title></caption><graphic xlink:href="nrp-11-290-i001"/><table-wrap-foot><fn><p><sup>1)</sup>Mean &#x000b1; SE</p><p>A/A, MCP-1 -2518 AA genotype; G/A, MCP-1 -2518 GA genotype; G/G, MCP-1 -2518 GG genotype.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Cytokine changes after spirulina supplementation for the A and G genotype subgroups</title></caption><graphic xlink:href="nrp-11-290-i002"/><table-wrap-foot><fn><p><sup>1)</sup>Mean &#x000b1; SE</p><p><sup>2)</sup>Significantly different by paired <italic>t</italic>-test between pre-test and post-test within the same genotype (<sup>*</sup><italic>P</italic> &#x0003c; 0.05).</p><p><sup>3)</sup>Determined by two-way ANOVA for main effects of MCP-1 genotype and spirulina supplementation, and interaction effects of MCP-1 genotype and spirulina supplementation.</p><p>A/A, MCP-1 -2518 AA genotype; G/A, MCP-1 -2518 GA genotype; G/G, MCP-1 -2518 GG genotype; NS, Not significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Changes in C3 and Ig after supplementation for A and G genotype subgroups</title></caption><graphic xlink:href="nrp-11-290-i003"/><table-wrap-foot><fn><p><sup>1)</sup>Mean &#x000b1; SE.</p><p><sup>2)</sup>Significantly different by paired <italic>t</italic>-test between pre-test and post-test within the same genotype (<sup>*</sup><italic>P</italic> &#x0003c; 0.05).</p><p><sup>3)</sup>Determined by two-way ANOVA for main effects MCP-1 genotype and spirulina supplementation, and interaction effects of MCP-1 genotype and spirulina supplementation.</p><p>A/A, MCP-1 -2518 AA genotype; G/A, MCP-1 -2518 GA genotype; G/G, MCP-1 -2518 GG genotype; NS, Not significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><title>Changes in lymphocyte proliferation rate from peripheral blood mononuclear cell based on MCP-1 genotype</title></caption><graphic xlink:href="nrp-11-290-i004"/><table-wrap-foot><fn><p><sup>1)</sup>Mean &#x000b1; SE.</p><p><sup>2)</sup>Significantly different by paired <italic>t</italic>-test between pre-test and post-test within the same genotype (<sup>*</sup><italic>P</italic> &#x0003c; 0.05).</p><p><sup>3)</sup>Determined by two-way ANOVA for main effects MCP-1 genotype and spirulina supplementation, and interaction effects of MCP-1 genotype and spirulina supplementation.</p><p>A/A, MCP-1 -2518 AA genotype; G/A, MCP-1 -2518 GA genotype; G/G, MCP-1 -2518 GG genotype; NS, Not significant.</p></fn></table-wrap-foot></table-wrap></floats-group></article>